NCT00318318View on ClinicalTrials.gov

Beneficial Effects of Oral Premarin Estrogen Replacement Therapy Assessed by Human Genome Array

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

December 31, 2006

Study Completion Date

February 28, 2007

Conditions
HealthyEstrogen Replacement Therapy
Interventions
DRUG

Premarin

Trial Locations (1)

N6A 4V2

Lawson Health Research Institute, London

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT00318318 - Beneficial Effects of Oral Premarin Estrogen Replacement Therapy Assessed by Human Genome Array | Biotech Hunter | Biotech Hunter